INTRODUCTION
The vitamin D receptor (VDR) is a ligand-activated transcription factor that mediates the genomic effects of 1,25-dihydroxyvitamin D in a wide variety of tissues. The gene encoding the VDR is located on chromosome 12q and has several common allelic variants. The individual allelic variants and their haplotypes have been widely studied as markers of susceptibility to osteoporosis, a prevalent metabolic bone disease characterized by reduced bone mass and a resultant increased susceptibility to fracture. More recent attention has focused on the possible role of VDR gene variation in the development of other diseases, including breast and prostate cancer, osteoarthritis, atherosclerotic coronary artery disease, diabetes, primary hyperparathyroidism, susceptibility to infection, and psoriasis. In this paper, we review the evidence for a role of common molecular variation in the VDR gene in osteoporosis and other diseases and discuss areas in need of further investigation.
VITAMIN D RECEPTOR GENE

Genomic organization
The VDR belongs to the steroid and thyroid hormone receptor family of ligand-activated transcription factors. The VDR mediates the effects of 1,25-dihydroxyvitamin D (1,25(OH) 2 D) on gene expression (1) . The gene encoding the VDR is located on chromosome 12cen-ql2 (2), contains 14 exons (3), and spans approximately 75 kilobases of genomic DNA (4) . Exons IA through IF encode the 5' untranslated region, exons II and III encode the DNA-binding domain, and exons FV-IX encode the ligand-binding region (3, 5) . The expression of the human VDR is under complex transcriptional control by multiple tissue-specific promoters (3).
At least 22 unique loss-of-function mutations in the VDR gene have been reported (6, 7) . Single nucleotide changes producing amino acid substitutions in the DNA-and ligandbinding domains are the predominate type of mutation found (6) . Less frequent mutations, including premature stop codons, cryptic splice sites, and a partial gene deletion, have also been described (6, 8, 9) . These mutations cause hereditary vitamin D-resistant rickets, a rare autosomal recessive disease resulting from target organ resistance to 1,25(OH) 2 D (6). An updated database of rare VDR mutations can be found on the Human Gene Mutation Database (http://www.uwcm.ac.uk/uwcm/mg/hgmdO.html).
Several common allelic variants have also been identified in the VDR gene and are the focus of the present review (figure 1) . The presence of a T/C transition polymorphism (ATG to ACG) at the first of two potential translation initiation sites in exon II (10) has been defined using the Fokl restriction endonuclease (11) . Individuals with the C allele (designated F) initiate translation at the second ATG site and lack the three NH 2~ terminal amino acids of the full-length VDR protein (12) . In contrast, individuals with the T allele (designated f) initiate translation at the first ATG site and synthesize the full-length (427 amino acids) VDR protein (12) . The ff genotype frequency was 4 percent among African Americans and 13-18 percent among Asians and Caucasians in one report (13) .
Bsml (14) and Apal (15) restriction site polymorphisms occur in the intron separating exons VIII and IX (figure 1). A T/C nucleotide substitution (ATT to ATC) leading to a synonymous change at codon 352 (isoleucine) in exon IX has also been described (16) and is detected by the restriction enzyme Taql. The Bsml and Fokl alleles do not appear to be in linkage disequilibrium (11, 13, 17, 18) , whereas a strong concordance exists between the absence of the Bsml (B allele) and presence of the Taql (t allele) sites (19) , and these sites show significant linkage disequilibrium with the Apal polymorphism. Hustmyer et al. (16) detected a rare third allele by Apal digestion in African Americans, but more recent PCR-based typing of the Apal polymorphism has not detected the presence of this allele. Morrison et al. (14) reported a fifth restriction site polymorphism, detected by southern blot analysis of EcoRV digested genomic DNA probed with a VDR complementary DNA probe, and Hustmyer et al. (16) showed that the frequency of the two alleles at this locus varied among Caucasians, African Americans, and Asians. The molecular basis of this polymorphism is unknown, and recent studies using PCR-based (20) . The frequency of Taql genotypes in these populations is similar to Bsml genotype frequencies. The Apal AA genotype frequency is 9 percent among Asians (21), 28 percent among Caucasians (22) , and 44 percent among African Americans (23) .
A mononucleotide repeat [(A)n] polymorphism that varies in length from 13 to 24 adenosines (12 alleles) (poly(A)) occurs in the 3' untranslated region of the VDR gene (24) . The distribution of allele size is bimodal, such that individuals can be classified as having short (A ]3 -A 17 ) or long (A 18 -A 24 ) alleles (24) . The frequency of short alleles in one study was 5-10 percent among Asians, 32 percent among African Americans, and 41 percent among Caucasians (24) . The longest alleles (A23-A24) in that study were found only among African Americans, whereas the shortest allele (A 13 ) was found only among Hispanics (24) .
Linkage disequilibrium has been reported between the poly(A) and Bsml alleles, such that the short poly(A) and Bsml B alleles (BS haplotype) and the long poly(A) and Bsml b alleles (bL haplotype) are coupled. Linkage disequilibrium is nearly complete among Caucasian Americans (disequilibrium coefficient, 0.96) and Japanese Americans (disequilibrium coefficient, 0.90), but is less pronounced among African Americans (disequilibrium coefficient, 0.53) (24) . Poly(A) and Fokl alleles do not appear to be in linkage disequilibrium (25, 26) .
VITAMIN D RECEPTOR ALLELIC VARIANTS AND OSTEOPOROTIC RISK
Early infant growth and skeletal size
Vitamin D regulates the differentiation and proliferation of cells responsible for skeletal and overall somatic growth (27) , and mice lacking the VDR gene experience severe growth retardation (28) . Several reports demonstrate that common VDR gene variants are associated with early infant growth and skeletal size, although these findings have been inconsistent, possibly because of the relatively small sample size of these studies. For example, girls aged 7 years with the TT genotype were 3.9 kg heavier (p = 0.03) and 4.1 cm taller (p = 0.008) than were those with the tt genotype in one study (29) , whereas in another self-reported body weight at age 1 year was significantly lower among adult women with the TT genotype (30) . Differences in age or ethnicity might also explain the conflicting findings of these studies.
Girls aged 2 years with the BB genotype were taller (p < 0.05) and heavier (p < 0.01) than were girls with the bb genotype (31) . In contrast, boys with the BB genotype weighed less (p < 0.01) than those with the bb genotype, an effect that was also observed at birth (31) . Lower height at birth, decreased growth during adolescence, and shorter adult stature has been confirmed among boys with the BB genotype (32) . The decreased body size among male infants with the BB genotype in another study was confined to those who were also homozygous for a PvuII site in intron one of the estrogen receptor gene (33) . Although less well studied, the Fokl variant has also been associated with stature in Japanese girls (34) . These data raise the possibility that molecular variation in the VDR gene influences intrauterine, early postnatal, and adolescent growth and that the effect may be modified by allelic variation in other growth-regulating genes and by gender.
Bone mass, postmenopausal bone loss, and osteoporotic risk Growth in infancy is associated with skeletal size and mass in adulthood (35) and may contribute to the development of osteoporosis, a prevalent metabolic bone disease characterized by low bone mass and a resultant increased susceptibility to fracture. The risk of fracture increases by as much as 2.5-to 3.0-fold with each standard deviation (SD) reduction in bone mass (36) . Bone mass and osteoporotic risk are under strong genetic control (37) , and the VDR gene has been studied widely as an osteoporosis candidate gene.
Most reports have examined the association between the Bsml polymorphism and bone mass. An initial study by Morrison et al. (19, 20, 38) documented about 0.5 SD or 8 percent lower (p < 0.01) spine bone mass in a sample of preand postmenopausal Australian women with the BB compared with bb genotypes. These findings were confirmed in some, but not all, subsequent studies (37) . In a meta-analysis of 16 reports published through July 1996 and involving over 3,600 subjects, the BB genotype was associated with 0.2 SD or 2.4 percent lower hip (p = 0.03) and 0.2 SD or 2.5 percent lower spine (p = 0.06) bone mass compared with the bb genotype (20) . More recently, Gong et al. (39) performed a qualitative meta-analysis of 75 reports and abstracts published up to January 1997 and involving more than 14,000 individuals. They concluded that VDR alleles (B, A, t) were associated with lower hip and spine bone mass more often than the expected 5 percent false-positive rate under the null hypothesis (39) . Studies were more likely to find a significant association between VDR alleles and bone mass among premenopausal than postmenopausal women or pre-and postmenopausal women combined and less likely to find a significant association if they included osteoporotic subjects. This suggests that the major effect of VDR genotype may be on peak bone mass rather than on age-or menopause-related bone loss.
Bone mass in the elderly is a product of both peak skeletal mass achieved during the first 3 decades of life and subsequent age-and menopause-related rates of bone loss. Although less well studied, allelic variants of the VDR gene have not been consistently associated with rates of bone loss among postmenopausal women. Three (40) (41) (42) of eight studies (22, 23, (40) (41) (42) (43) (44) (45) have found significantly greater postmenopausal bone loss associated with the B allele. Three studies did not find a significant association between the Taql polymorphism and bone loss (22, 44, 46) , although we documented a significantly greater rate of hip bone loss among older (>70 years), but not younger (<70 years), African-American women with the tt genotype (23) . Most studies had fewer than 100 subjects and less than 2 years of follow-up and may have lacked adequate statistical power to detect differences between genotypes. For example, a more than twofold greater rate of spinal bone loss among postmenopausal women (n = 109) with the BB or tt genotype did not achieve statistical significance in one study (22) . Postmenopausal MexicanAmerican women with the Fokl ff genotype experienced significantly greater hip bone loss compared with women with either the Ff or FF genotypes (11) , although this finding was not confirmed in a subsequent study of CaucasianAmerican women (47) .
Two (48, 49) of eight studies (48) (49) (50) (51) (52) (53) (54) (55) have demonstrated a significant difference in VDR genotype or haplotype distribution between osteoporotic patients and controls. Most studies included fewer than 100 cases, so it is possible that small differences in genotype frequencies were missed. The largest study to date (49) found that the homozygous BAt haplotype was significantly more prevalent among 176 osteoporotic Italian women compared with 144 controls (24 vs. 8 percent, respectively; p < 0.01), whereas the homozygous baT haplotype was less common among osteoporotic women (7 vs. 18 percent, respectively; p < 0.01).
More recent studies have focused on the Fokl variant in exon 2. Initial reports of this polymorphism found 11-12 percent (approximately 1 SD) lower bone mass at the hip and spine in Japanese (12), Mexican-American (11), and Caucasian-American (56) women with the ff compared with FF genotypes. Subsequent reports have not confirmed significant associations between the Fokl variant and bone mass, and differences between homozygous genotypes have generally been much smaller (approximately 2-5 percent or <0.3 SD) (13, 17, 18, (57) (58) (59) (60) (61) . Most studies have lacked sufficient statistical power to detect differences of this magnitude. Moreover, ethnic (genetic) background may modify the effects of this polymorphism (56) . There may also be effect modification by unlinked loci (modifier genes) (62) and environmental factors such as dietary calcium intake (42, (63) (64) (65) ) that remain to be fully explored.
The physiologic mechanisms mediating the associations between VDR gene variants and bone mass are unclear but are probably due to established actions of vitamin D on calcium homeostasis. For example, 1,25(OH) 2 D and its receptor mediates active intestinal calcium absorption (66) , and calcium absorption has been reduced in subjects with the BB genotype (23, 67, 68) and homozygous BAt haplotype (68, 69) . These associations may be more pronounced among subjects with low dietary calcium intake (67) . Premenopausal women with the BAt haplotype had 11 percent lower (69) and postmenopausal women had 37 percent lower (68) calcium absorption compared with women with the baT haplotype (p < 0.05). Thus, the effect of VDR gene variation on calcium absorption may also be modified by age or hormonal status. An additive effect of Fokl alleles on calcium absorption has also been demonstrated among children (70) . Calcium absorption was 41.5 percent greater in children who were FF than ff homozygotes and was 17 percent greater in heterozygotes (70) . However, associations between VDR genotype and calcium absorption have not been confirmed in all studies (71) (72) (73) . Nevertheless, these results suggest that there may be VDR genotype-dependent differences in intestinal sensitivity to 1,25(OH) 2 D.
Osteoporotic fracture
There have been relatively few studies of VDR gene variants and the risk of osteoporotic fractures (table 1 ). An ecologic analysis of 14 published studies suggested that higher population frequencies of the TT genotype are associated with lower, age-adjusted hip fracture rates (79), consistent with studies showing that this polymorphism is associated with greater bone mass. Feskanich et al. (74) found a 2.4-fold greater risk (95 percent confidence interval (CI): 1.1, 5.2) of hip fracture associated with the BB compared with the Bb or bb genotypes in a nested casecontrol study of Caucasian-American women aged 43-69 years. The increased risk of fracture associated with the BB genotype in this study is much greater than that expected based on the small differences in bone mass associated with this polymorphism. Uitterlinden et al. (75) (74) and suggests that different alleles may be associated with fracture in different populations (i.e., allelic heterogeneity). Interestingly, the increased risk of fracture associated with the baT haplotype was independent of bone mass, raising the possibility that factors other than low bone mass explain the association between VDR haplotype and fracture risk (75) . Nevertheless, in the largest study to date, we were unable to confirm a relation between the Taql and Apal variants, either alone or in combination, and the incidence of hip, spine, or other fractures in a case-cohort study nested within a prospective study of 9,704 Caucasian-American women aged 65 years and older (76) . Analyses stratified by age (<75 vs. >75 years), calcaneal bone mass (<0.40 vs. >0.40 mg/cm 2 ), and dietary calcium intake (<640 vs. >640 mg/day) produced similar results.
The relation between the Fokl variant and fracture risk has been less well studied. Gennari et al. (61) found that the ff genotype was overrepresented among postmenopausal women with vertebral fractures (25 percent) compared with controls (11 percent), equivalent to an odds ratio of 2.6 (95 percent Cl: 1.4, 4.9). These findings have not been replicated in other populations yet.
Gene-environment interactions
The risk of osteoporosis associated with VDR genotype may be modified by age, diet, and other lifestyle factors. Failing to account for such interactions may mask an association with VDR genotype. For instance, an increased risk of hip fracture associated with the BB genotype was greatest among women who were older, leaner, and less active and among those with lower dietary calcium intake in one study (74) . Other small clinical trials found that VDR genotype is associated with the bone mass response to vitamin D supplementation (80, 81) . Two exercise Vitamin D Receptor Gene Polymorphisms 207 intervention studies (82, 83) did not find significant VDR genotype differences in changes in bone mass, perhaps because of their small sample size (<35 subjects). Larger trials will be necessary to convincingly demonstrate that VDR genotype influences the response to dietary or lifestyle modifications. Nevertheless, research addressing the influence of gene-environment interactions may suggest novel strategies for preventing or delaying the onset of this disease.
Gene-gene interactions
The association between VDR gene variation and risk of osteoporosis may also be modified by allelic variation in other candidate genes. For example, Willing et al. (62) found that the Bsml polymorphism alone was not significantly associated with bone mass at the spine among premenopausal Caucasian women. However, bone mass was 15 percent, or more than 1 SD, lower among women with the BB genotype who were also homozygous for the absence of a PvuII variant in intron one of the estrogen receptor alpha gene (j? < 0.05 for interaction). In another report, a complex interaction between the two-locus VDRestrogen receptor alpha genotype and hormone replacement therapy in modifying calcaneal ultrasound measures was documented (84) . These interactions are biologically plausible because estrogen can increase the number and expression of VDR in osteoblast (85, 86) and duodenal mucosa cells (87) . The risk of fracture per copy of the baT haplotype was 1.1 (95 percent CI: 0.7, 1.6) among women with the G/G genotype at an Spl binding site in the type Ial collagen gene and 2.6 (95 percent CI: 1.6, 4.5) among those with the G/T or T/T genotype (p < 0.05 for interaction) (75) . Thus, the influence of VDR genotype on osteoporotic risk may depend on the presence or absence of allelic variants at other unlinked loci.
Summary
Bone mass is under strong genetic control, but the specific genes and allelic variants contributing to bone mass and osteoporotic risk are not well defined (37) . The VDR gene has been widely studied as an osteoporosis candidate gene during the past several years, with most reports focusing on a Bsml restriction fragment length polymorphism in intron 8. The homozygous absence of this site has been associated with a small decrease (2 percent) in bone mass in a large meta-analysis and with an increase in hip fracture risk in one study, although attempts to replicate these later findings have been unsuccessful. A potentially functional Fokl polymorphism in exon 2 has also been associated with modest differences in bone mass in some studies and with vertebral fracture risk in one report, although, again, these findings have been inconsistent. The strength of association with VDR polymorphisms has been modified by molecular variation in other genes and other risk factors such as age and dietary calcium intake in some reports. This suggests that VDR allelic effects may be context dependent and that there may be larger VDR effects in certain subgroups in the population. (91-93, 96, 98) . However, associations were stronger for more advanced disease in some reports (90, 91) , suggesting that VDR allelic variants may influence the progression, rather than initiation, of prostate cancer.
VITAMIN D RECEPTOR ALLELIC VARIANTS AND OTHER DISEASES
Vitamin D may also play a role in normal prostate growth (99) , and one recent study demonstrated an association between the VDR Bsml polymorphism and risk of benign prostatic hypertrophy (97) . Thus, inclusion of men with benign prostatic hypertrophy as controls may have masked or attenuated an association between VDR polymorphisms and prostate cancer in some studies.
At least seven studies have examined the association between VDR allelic variants and breast cancer risk (table  3 ). An initial report found nearly fourfold greater risk of breast cancer associated with the homozygous presence of the Bsml site among Japanese women (105), which is consistent with the threefold increases in prostate cancer risk among Japanese men with this VDR genotype (97) . Subsequent reports have demonstrated similar (more than twofold) increases in breast cancer risk among women homozygous for the presence of the Apal (101), Fokl (26), or short poly(A) alleles (100), although these findings have not been universal (100, 101) , and in one study, the homozygous presence of the Bsml site was associated with a decreased risk of breast cancer among Latina women (100). In two studies, an association was found for VDR genotype and metastatic, but not overall, disease risk (103, 104) , suggesting that VDR allelic variants may influence tumor progression rather than development.
Osteoarthritis
Vitamin D receptor allelic variants have also been associated with prevalent osteoarthritis in some studies. The presence of the baT haplotype (106) or T allele (107) was associated with an approximately 2.5-fold increase in the risk of knee osteoarthritis, which was independent of age, body mass index, and bone mass in two case-control studies. This relation was explained largely by an association with osteophytes rather than joint space narrowing in one study (106) , suggesting that VDR genotype may influence particular features of osteoarthritis. Biologic support for this association comes from studies showing that serum levels of vitamin D are related to the progression of knee osteoarthritis (108) (109), a cellular component of osteophytes (110) . In contrast to these findings, the Taql T allele was associated with a decreased risk of spine osteoarthritis (111) , and the Bsml variant was not significantly associated with hip osteoarthritis (total hip replacement) (112) in other studies. These studies are limited by their cross-sectional design, small sample size, and focus on Caucasian subjects. Prospective studies in larger and more diverse populations are needed to test whether VDR genotypes and haplotypes are associated with the incidence and progression of radiographically defined osteoarthritis.
Hyperparathyroidism
The vitamin D receptor mediates the inhibitory effects of vitamin D on parathyroid hormone (PTH) secretion (113) and parathyroid cell proliferation (114, 115) . Recent studies suggest that VDR gene variants may be associated with primary hyperparathyroidism (116-120), a common disease often caused by benign parathyroid adenoma or parathyroid hyperplasia and accompanied by excessive PTH secretion (121). Carling et al. (116, 118) found that the b, a, and T alleles were significantly more common among patients with primary hyperparathyroidism than among age-matched controls. The estimated risk of primary hyperparathyroidism was 2.5-fold greater (95 percent CI: 1.3, 5.1) among women with the baT haplotype compared with those without diis haplotype (118) . Consistent with these findings, PTH messenger RNA levels were nearly 60 percent higher among patients with the baT haplotype compared with those with other haplotypes (119) . The presence of the Bsml (122, 123) and Apal (124) restriction sites has also been associated with elevated PTH levels in patients with end-stage renal disease, suggesting that VDR gene variants may influence the development or severity of secondary hyperparathyroidism in such patients.
Diabetes
Transmission disequilibrium testing in 93 Indian families revealed that the b allele and bT and bAT haplotypes are preferentially transmitted from parents to offspring affected with type I diabetes (125) . Insulin secretion was 30-50 percent lower (p < 0.05) in nondiabetic Bangladeshi Asians with the bb, aa, or TT genotypes compared with the BB, A A, or tt genotypes, respectively (126) . These results are consistent with the presence of vitamin D receptors in pancreatic (3-cells (127) and with studies showing that vitamin D deficiency impairs insulin secretion (128) and that vitamin D treatment prevents the development of type I diabetes in the nonobese diabetic mouse model (129) . No exposures assessed.
No exposures assessed.
No exposures assessed. 
Infectious diseases
The immune system is a well-known target of vitamin D (134), and children with hereditary vitamin D-resistant rickets may have impaired phagocytosis and neutrophil motility and an increased number and severity of infections (135) . Moreover, administration of 1,25(OH) 2 D inhibits growth of Mycobacterium tuberculosis in human macrophages and monocytic cells in vitro (136) . Bellamy et al. (137) reported that the Taql tt genotype was significantly underrepresented in patients infected with pulmonary tuberculosis (6.6 percent) and hepatitis B (7.3 percent) compared with controls (12 percent and 14 percent, respectively). A smaller, subsequent study also noted a lower frequency of the tt genotype among tuberculosis patients (6 percent) compared with their uninfected contacts (11 percent), although this difference did not achieve statistical significance (p = 0.49) (138). However, there was significant interaction between 25-hydroxycholecalciferol status and VDR genotype (138) . The combination of the TT/Tt genotypes and 25-hydroxycholecalciferol deficiency was associated with a 2.8-fold (95 percent CI: 1.2, 6.5) increased risk of tuberculosis. A similar interaction between the Fokl ff genotype and vitamin D status was also observed. Roy et al. (139) also found that the Taql polymorphism is associated with susceptibility to Mycobacterium leprae infection in general and also to leprosy type. The estimated risk of tuberculoid leprosy was threefold greater (95 percent CI: 1.5, 7.1) among Bengali subjects with the tt compared with TT genotypes. In contrast, there was a 67 percent increase (95 percent CI: 1.02, 2.75) in the risk of lepromatous leprosy in subjects with the TT compared with tt genotypes. The possibility that common molecular variation in the VDR gene makes a broader contribution to host susceptibility to infectious diseases merits further investigation.
Psoriasis
Psoriasis is a chronic skin disease characterized by hyperproliferation of keratinocytes and inflammation (140) . The observations that keratinocytes contain receptors for 1,25(OH) 2 D (141) and that active metabolites of vitamin D inhibit proliferation of these cells (142) prompted recent studies of the association between VDR allelic variants and psoriasis (143) (144) (145) Kontula et al. (145) were unable to document a difference in Bsml allele and genotype distribution between psoriatic patients who did {n = 10) and those who did not (n = 9) respond to topical calcipotriol treatment.
Summary
In addition to bone mass and osteoporotic risk, VDR polymorphisms have been associated with several other diseases, including breast and prostate cancer, osteoarthritis, hyperparathyroidism, coronary artery disease, psoriasis, and infection. More recent reports also suggest a possible association between molecular variation in the VDR gene and multiple sclerosis (147) , sarcoidosis (148) , early-onset periodontal disease (149) , and nephrolithiasis (150), although these later studies have included few cases, and replication of these findings in larger populations and other ethnic groups is clearly needed.
There is also a need to explore the relation between VDR genotype and other malignancies. For instance, the homozygous presence of the VDR Fokl site was recently associated with a 70 percent increase (95 percent CI: 1.1, 2.6) in the risk of malignant melanoma (151) , consistent with the expression of VDR in normal and malignant melanocytes and the antiproliferative effects of 1,25 (OH) 2 vitamin D on these cells in vitro (88) . Vitamin D influences the proliferation and differentiation of other malignant cell lines, including colon and leukemia (88) . Thus, investigations of VDR genotype and the development and progression of these other malignancies may be an important future endeavor.
The effect of VDR polymorphisms on disease risk may be context dependent, and few studies to date have examined possible interactions between VDR polymorphisms and environmental exposures. The Physicians Health Study, for example, found a significant reduction in prostate cancer risk associated with the VDR BB or tt genotypes, but only among men with the lowest serum 25(OH) vitamin D levels (92) . Thus, future investigations of VDR genotypes and disease risk may need to assess and stratify by serum vitamin D levels. It will also be important to test for possible interactions between VDR alleles and molecular variation in other candidate genes.
FUNCTIONAL CONSEQUENCES OF VDR ALLELIC VARIANTS
The possible functional consequences of VDR alleles remain unclear. The Apal and Bsml variants are unlikely to have functional consequences, since both sites are located in the intron between exons VHI and IX and neither variant is near the intron-exon boundaries or known to produce splic-212 Zmudaetal.
ing errors. Moreover, several studies have found similar VDR protein (73, 152, 153) and messenger RNA (mRNA) levels (152, 154) , ligand-binding affinity (152) , DNA binding (152) , and transactivation function (152) between Bsml genotypes, although these observations have not been universal (119) . The Taql polymorphism is also unlikely to directly affect VDR function, since both alleles code for isoleucine at amino acid 352.
Several studies have also examined the association between the common BsmVApaVTaql haplotypes and VDR function. Morrison et al. (19) showed that COS-7 and rat osteosarcoma cells transfected with reporter gene constructs containing the baT haplotype had significantly lower luciferase activity than did those with the BAt haplotype. Consistent with these observations, the baT haplotype has been associated with significantly lower VDR mRNA levels in parathyroid adenomas of patients with primary hyperparathyroidism (119) . In contrast to these studies, Beaumont et al. (155) recently demonstrated significantly greater luciferase activity with reporter gene constructs containing the baT haplotype in transfected human osteoblast and osteosarcoma cell lines. One possible explanation for these inconsistent findings may be that the effect of VDR allelic variants on VDR function is tissue and/or species specific.
The Fokl variant remains a candidate functional polymorphism. Colin et al. (156) found that phytohemoglutininstimulated growth of peripheral blood monocytes differs by Fokl genotype. They demonstrated that the one-half maximal concentration for 1,25(OH) 2 vitamin D inhibition of phytohemoglutinin-stimulated growth was significantly higher for cells containing the full-length VDR isoform (i.e., Ff and ff genotypes) than for those with the shorter isoform (FF genotype). Interestingly, there were no genotype-related differences in maximal inhibition of growth, raising the possibility that genotypic effects may be most apparent among individuals with low 1,25(OH) 2 vitamin D levels. Transfection experiments in COS-7, HeLa, and fibroblast cell lines have also shown that the full-length VDR isoform has a decreased ability to induce transcriptional activation of reporter genes in response to 1,25(OH) 2 D compared with the shorter F allele isoform (12, 25) , although these observations were not confirmed in another study (157) . The f allele isoform interacts with the basal transcription factor HB less efficiently than does the F allele isoform, providing a possible mechanism for the reduced transactivation associated with this allele (158) . The 3' poly(A) allelic variants do not appear to alter VDR mRNA stability (159) .
Summary
The 3' Bsml, Apal, and Taql polymorphisms do not appear to alter VDR gene expression or VDR function. Disease associations with these polymorphisms are therefore most likely due to linkage disequilibrium with other functional variation within the VDR gene or with another closely linked gene or genes. The 5' Fokl polymorphism remains a potentially functional variant, but does not appear to be in linkage disequilibrium with the Bsml, Apal, or Taql polymorphisms in most populations studied thus far. This raises the possibility that there may be additional functional polymorphisms in the VDR gene that remain to be characterized.
CONCLUSIONS AND FUTURE DIRECTIONS
The possible role of VDR gene variation in osteoporosis susceptibility has been a subject of intense investigation during the past several years. Numerous studies have found that the homozygous absence of a Bsml restriction site in intron 8 is associated with a modest reduction in bone mass and possible increase in the risk of fracture; however, others have found no such associations. Conflicting results are not unexpected in association studies and may arise for several reasons, including differences in ethnic (genetic) background, gene-gene and gene-environment interactions, and the definition of the phenotype. Inappropriate selection of controls is the major confounding factor in association studies, however, and differences in subject ascertainment may also contribute to discrepant and sometimes spurious results. For instance, the distribution of VDR genotypes was not in Hardy-Weinberg equilibrium (i.e., genotype frequencies were not predicted by allele frequencies) in some studies. Departures from Hardy-Weinberg equilibrium may arise for several reasons apart from genotyping errors, including chance fluctuations due to small samples, nonrandom mating, migration into or out of the population, selective survivorship among genotypes, population stratification, and admixture of different ethnic groups (160) . Deviations from Hardy-Weinberg equilibrium can bias the type I error rate such that the chance of a false-positive association increases substantially if the proportion of homozygotes with the high-risk allele is more common in the general population than predicted by Hardy-Weinberg equilibrium (161) . Appropriate selection of controls is thus essential in association studies, but can be difficult due to unrecognized confounding by ethnic, ancestry, or admixture differences between cases and controls. Family-based association tests, such as the transmission-disequilibrium test (TDT), avoid confounding due to population stratification or admixture (162) (163) (164) , but have rarely been used in studies of VDR alleles (125) . The TDT test compares allele frequencies in cases with the frequencies of nontransmitted alleles in parents, thereby eliminating the need for ethnically matched controls. Recent modifications to the TDT make it a more practical tool for the study of quantitative traits such as bone mass (165) . Future investigations of VDR gene variation should use family-based association methods to validate the results of population-based studies.
A major difficulty in accepting the hypothesis that known VDR allelic variants are directly responsible for the observed associations is that none of the variants, with the possible exception of the Fokl polymorphism, have consistently altered VDR expression or function in vitro. The inconsistent study results and doubtful functional significance of several known VDR gene variants suggest that other DNA sequence variation within the coding or regulatory regions of the VDR gene should be sought. Identifying die functional variant(s) will be a challenging task. Sequencing the VDR gene in subjects with contrasting levels of bone mass might maximize the Vitamin D Receptor Gene Polymorphisms 213 chances of detecting new functional variation. Sequencing studies in populations with different evolutionary histories may also help to localize the major functional variation. Such studies will also provide a more complete picture of the nucleotide diversity and structure of linkage disequilibrium across the VDR gene. Statistical approaches for identifying the probable functional variation or at least reducing the number of candidates requiring further investigation, such as multiple DNA variant association (166) and cladistic (167) analysis, are available and may help to localize the functional variation.
Interest in identifying novel functional variation at the VDR locus is strengthened by the possible association of VDR alleles with several major diseases. Interestingly, the allele associated with potentially beneficial effects on bone mass at the Bsml site (b allele) has also been associated with an increased risk of breast and prostate cancer, atherosclerotic coronary artery disease, and primary hyperparathyroidism in some studies. An association of the b allele with both increased bone mass and breast cancer risk is consistent with the increased rates of breast cancer among women with high bone mass (168) , raising the possibility of a genetic link between these common conditions. The paradoxical association of VDR alleles with high bone mass yet increased risk of late-in-life diseases is consistent with the antagonistic pleiotropy theory of aging, which proposed that alleles with beneficial effects early in life will have detrimental effects during the later stages of life (169) . Nevertheless, understanding the potential role of VDR gene variation in these other common, chronic conditions may suggest new approaches to their prevention and treatment.
